- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00338572
Effect of Exercise and Diet on Inflammation in Hypertensive Individuals
Sympathetic Nervous System Regulation of Cell Adhesion
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Hypertension is characterized by high blood pressure, as well as by inflammation and increased adhesion among blood cells. Inflammation may play an important role in atherosclerosis, which involves the build up of fatty deposits on the inside wall of arteries. Pharmacological treatment for hypertension successfully reduces blood pressure. However, it has limited effectiveness for reducing the associated inflammation. Losing weight and increasing physical activity have been shown to reduce general inflammation, but more research is needed to determine their effect on inflammation that is directly related to hypertension. The purpose of this study is to evaluate the effectiveness of an exercise program versus a combined exercise and diet program at reducing inflammation and cell adhesion in hypertensive individuals.
This study will enroll inactive and overweight hypertensive individuals. Participants will be randomly assigned to a 12-week exercise program, a 12-week combined exercise and diet program, or a non-intervention group. At study entry, participants will take part in a speech stressor task, a VO2 peak exercise test, and an exercise treadmill test. During the speech stressor task, participants will be videotaped while they talk about potentially stressful situations. Prior to and following the speech task, blood will be collected, blood pressure and heart rate will be recorded, and standardized questionnaires will be completed to assess anger, anxiety, and stress levels. The two exercise tests will occur within 5 days of each other and both will involve running on a treadmill. Heart rate, respiratory rate, and physical activity intensity will be monitored; heart activity will be measured by an electrocardiogram (ECG). Blood will be collected at various times during the testing procedures to measure levels of inflammation biomarkers, including C-reactive protein (CRP) and white blood cells. Perceived exertion and stress levels will also be assessed.
Participants in the exercise intervention will receive a 12-week membership to the YMCA and will meet with a personal trainer twice a week. They will be encouraged to exercise on their own for an additional 3 to 4 days per week. Participants will also be provided with a pedometer, which will track the number of steps they take each day. Participants in the diet program will meet with a dietician and will be encouraged to reduce their caloric intake by incorporating low-fat, high-fiber foods into their diet. Throughout the study, participants will have regular follow-up phone calls with study staff and meetings with their personal trainer and/or dietician to ensure that they are adhering to their assigned program. At the end of 12 weeks, participants will return for a repeat speech stressor task, a VO2 peak exercise test, and an exercise treadmill test. Participants in the non-intervention group will then be assigned to either the exercise program or combined exercise and diet program.
Type d'étude
Inscription (Réel)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
California
-
San Diego, California, États-Unis, 92103
- University of California, San Diego
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Unmedicated hypertension with blood pressure greater than 140/90 mm Hg but less than 175/104 mm Hg
- Body mass index (BMI) of 23.5 to 34
- Relatively inactive, as defined by the Leisure Time Exercise Questionnaire
- Willing and able to participate in the assigned study group
- Postmenopausal women not on hormone replacement therapy (HRT) and premenopausal women
Exclusion Criteria:
- Abnormal echocardiogram
- Recent stroke or significant brain impairment
- Current psychiatric disease
- History of psychosis or major depression
- Currently taking psychotropic drugs
- Currently taking any medications (e.g., anti-inflammatory medications) other than antihypertensives (which will be tapered)
- Current drug and/or alcohol abuse
- Consumes more than 600 mg of caffeine per day
- Diabetes
- Congestive heart failure
- Bronchospastic pulmonary disease
- History of heart attacks
- Known secondary high blood pressure
- Angina
- History of life-threatening arrhythmias
- History of kidney damage
- Current participation in regular or structured exercise classes, or regular physical exercise in the 6 months prior to study entry
- Inability to perform moderate to vigorous intensity exercise
- Current participation in a diet
- High blood pressure, only when measured in a doctor's office (i.e., "white coat hypertension")
- Arthritis, exertional asthma, or any other disorder likely to be made worse by exercise
- Pregnant
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation croisée
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
---|---|
Comparateur actif: 1
12-week exercise program
|
Participants in the exercise group will receive a 12-week membership to the YMCA and will meet with a personal trainer twice a week.
They will be encouraged to exercise on their own for an additional 3 to 4 days per week.
Participants will also be provided with a pedometer, which will track the number of steps they take each day.
|
Expérimental: 2
12-week combined exercise and diet program
|
Participants in this group will receive a 12-week membership to the YMCA and will meet with a personal trainer twice a week.
They will be encouraged to exercise on their own for an additional 3 to 4 days per week.
Participants will also be provided with a pedometer, which will track the number of steps they take each day.
They will meet with a dietician and will be encouraged to reduce their caloric intake by incorporating low-fat, high-fiber foods into their diet.
|
Aucune intervention: 3
Non-intervention group
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
---|---|
CRP
Délai: Measured at 4 years
|
Measured at 4 years
|
Interleukin-6 (IL-6)
Délai: Measured at 4 years
|
Measured at 4 years
|
Tumor necrosis factor-alpha (TNF-alpha)
Délai: Measured at 4 years
|
Measured at 4 years
|
Soluble intercellular adhesion molecule-1 (sICAM-1)
Délai: Measured at 4 years
|
Measured at 4 years
|
SE-selectin
Délai: Measured at 4 years
|
Measured at 4 years
|
Leukocyte CD11a expression
Délai: Measured at 4 years
|
Measured at 4 years
|
Leukocyte CD11b expression
Délai: Measured at 4 years
|
Measured at 4 years
|
Leukocyte activation
Délai: Measured at 4 years
|
Measured at 4 years
|
Peripheral blood mononuclear cell chemotaxis
Délai: Measured at 4 years
|
Measured at 4 years
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
---|---|
Physical fitness
Délai: Measured at 4 years
|
Measured at 4 years
|
Weight
Délai: Measured at 4 years
|
Measured at 4 years
|
Blood pressure
Délai: Measured at 4 years
|
Measured at 4 years
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Paul J. Mills, PhD, University of California, San Diego
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- 380
- R01HL057265 (Subvention/contrat des NIH des États-Unis)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .
Essais cliniques sur Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecrutementHypertension Essentielle | Hypertension, masquéTaïwan
-
University of Alabama at BirminghamTroy UniversityComplétéHypertension | Hypertension, résistante à la thérapie conventionnelle | Hypertension non contrôlée | Hypertension, blouse blancheÉtats-Unis
-
Amsterdam UMC, location VUmcZonMw: The Netherlands Organisation for Health Research and DevelopmentInconnue
-
Vanderbilt University Medical CenterJohns Hopkins UniversityComplétéHypertension artérielle pulmonaire | Hypertension artérielle pulmonaire idiopathique | Hypertension artérielle pulmonaire associée | Hypertension artérielle pulmonaire héréditaireÉtats-Unis
-
Assistance Publique - Hôpitaux de ParisActif, ne recrute pasHypertension portale non cirrhotique intrahépatiqueFrance
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldComplétéHypertension artérielle pulmonaire idiopathique | Hypertension pulmonaire thromboembolique chroniqueRoyaume-Uni
-
BayerComplété
-
Centre Chirurgical Marie LannelongueInconnueHypertension pulmonaire thromboembolique chronique et hypertension artérielle pulmonaireFrance
-
AstraZenecaComplétéHypertension artérielle (hypertension).
-
University of VermontInconnue
Essais cliniques sur Exercise Program
-
IWK Health CentreCanadian Institutes of Health Research (CIHR)Complété
-
Akdeniz UniversityPas encore de recrutementAVC ischémique | EncadrementTurquie
-
Johns Hopkins UniversityThe Rita and Alex Hillman Foundation; Abell Foundation; Richman Foundation; Sherman... et autres collaborateursRecrutementParentalité | Intervention parentaleÉtats-Unis
-
University of Texas Rio Grande ValleyHealth and Human Services Commission (HHSC); Pharr-San Juan-Alamo Independent... et autres collaborateursActif, ne recrute pasComportement lié à la santéÉtats-Unis
-
Children's HealthActif, ne recrute pasTroubles du spectre autistiqueÉtats-Unis
-
The University of Hong KongSydney Children's Hospitals Network; SAHKRecrutementTroubles du spectre autistiqueHong Kong
-
Hospices Civils de LyonRésilié
-
Microclinic InternationalRoyal Health Awareness Society (RHAS); Jordanian Ministry of Health (MoH)ComplétéHyperglycémie | Hypertension | Obésité | Diabète sucré, Type 2 | Diabète sucré | Diabète | Poids | Perte de poids | Pression artérielle | Gain de poids | Comportement social | Poids, Corps | Glycémie, hypertension | Mode de vie, Sain | Changement de poids, Corps | Comportement, Santé | Réduction des risques liés au mode... et d'autres conditionsJordan
-
Lady Davis InstituteComplétéSclérodermie systémiqueCanada
-
Bispebjerg HospitalAarhus University Hospital Skejby; Rigshospitalet, Denmark; Danish Cancer SocietyComplétéCancer | Arrêt du tabac | Tabagisme